https://www.entis-org.eu/courses/entis-meeting-prague-czech-republic-september-17-20-2015 2018-12-19T12:56:33+00:00 monthly 0.2 https://www.entis-org.eu/news/zika-virus-a-new-infectious-teratogen-alarming-observations-from-brazil 2017-02-03T13:15:55+00:00 monthly 0.2 https://www.entis-org.eu/courses/final-programme-of-the-entis-isop-nfif-training-course-risk-assessment-of-drug-use-during-pregnancy-and-lactation-and-26-th-entis-conference-and-is-now-available 2018-12-19T12:56:21+00:00 monthly 0.2 https://www.entis-org.eu/courses/news-from-the-entis-isop-nfif-education-course-and-the-27th-annual-entis-conference-2016 2018-12-19T12:56:13+00:00 monthly 0.2 https://www.entis-org.eu/entis-study/entis-study-questions-the-safety-of-pregabalin-during-pregnancy 2018-10-17T07:57:02+00:00 monthly 0.2 https://www.entis-org.eu/courses/first-announcement-of-the-28th-conference-of-the-european-network-of-teratology-information-services-saturday-2nd-to-tuesday-5th-september-2017-budapest 2018-12-19T12:56:04+00:00 monthly 0.2 https://www.entis-org.eu/news/recent-letter-by-entis-members-question-the-ema-warning-on-paternal-use-of-mycophenolate-mofetil 2018-10-17T07:56:45+00:00 monthly 0.2 https://www.entis-org.eu/entis-study/publication-of-recent-study-of-pregnancy-outcome-after-methylphenidate-exposure 2017-02-03T13:15:55+00:00 monthly 0.2 https://www.entis-org.eu/news/antipsychotics-in-pregnancy-large-cohort-study-from-the-us-investigates-risk-for-congenital-malformations 2017-02-03T13:15:55+00:00 monthly 0.2 https://www.entis-org.eu/news/collaborative-entis-study-into-the-risk-of-adverse-pregnancy-outcomes-following-maternal-varenicline-use 2018-10-17T07:56:32+00:00 monthly 0.2 https://www.entis-org.eu/uncategorised/ace-inhibitors-in-pregnancy-recent-study-from-the-u-s-suggests-no-increase-in-risk-of-major-malformations-with-exposure-during-the-first-trimester 2017-02-06T08:16:43+00:00 monthly 0.2 https://www.entis-org.eu/courses/registrations-open-for-the-28th-conference-of-the-european-network-of-teratology-information-services-and-education-course-saturday-2nd-to-tuesday-5th-september-2017 2018-12-19T12:55:53+00:00 monthly 0.2 https://www.entis-org.eu/meetings/past-meetings/final-programme-for-the-28th-conference-of-the-european-network-of-teratology-information-services-and-the-joint-entis-ets-education-course-budapest-saturday-2nd-to-tuesday-5th-september-2017-is-n 2018-12-19T12:55:09+00:00 monthly 0.2 https://www.entis-org.eu/uncategorised/3rd-international-joint-meeting-of-the-european-network-of-teratology-information-services-entis-and-organization-of-teratology-information-specialists-otis-and-teratology-education-course 2018-09-19T09:06:56+00:00 monthly 0.2 https://www.entis-org.eu/uncategorised/otisentis-teratology-education-course-2018 2018-09-19T09:06:35+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/end-of-3rd-international-meeting-notice 2018-12-19T12:54:54+00:00 monthly 0.2 https://www.entis-org.eu/meetings/next-meeting-announcement 2018-11-22T09:51:01+00:00 monthly 0.2 https://www.entis-org.eu/news/birth-defects-surveillance-an-interesting-commentary-on-the-value-of-data-sharing-and-networking 2018-10-08T21:10:09+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnant-a-dutch-pregnancy-drug-register 2018-10-08T21:09:41+00:00 monthly 0.2 https://www.entis-org.eu/news/birth-defect-risks-following-maternal-use-of-antihypertensives 2018-10-08T21:09:25+00:00 monthly 0.2 https://www.entis-org.eu/news/methods-for-assessing-selection-bias-in-pregnancy-pharmacovigilance 2018-10-08T21:09:06+00:00 monthly 0.2 https://www.entis-org.eu/news/birth-defect-surveillance-using-social-media-data 2018-10-17T07:52:57+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-concerning-the-safety-of-gestational-vedolizumab-use 2018-10-17T07:53:12+00:00 monthly 0.2 https://www.entis-org.eu/news/safety-of-adalimumab-exposure-in-pregnancy 2018-10-17T07:53:27+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-regarding-%ce%b2-blocker-use-in-pregnancy 2018-10-22T20:13:32+00:00 monthly 0.2 https://www.entis-org.eu/news/the-treatment-and-prevention-of-malaria-in-pregnancy 2018-12-06T21:36:19+00:00 monthly 0.2 https://www.entis-org.eu/news/how-to-manage-hypretension-during-pregnancy 2018-10-30T13:39:52+00:00 monthly 0.2 https://www.entis-org.eu/news/reassuring-data-concerning-the-safety-of-inactivated-influenza-vaccines-in-pregnancy 2018-11-08T12:34:13+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-honorary-membership-award-bracha-stahl 2019-04-11T20:06:19+00:00 monthly 0.2 https://www.entis-org.eu/news/intellectual-difficulties-in-patients-with-fatal-valproate-syndrome 2018-11-29T11:42:54+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-provides-timely-data-concerning-raltegravir-or-elvitegravir-exposure-in-pregnancy 2018-12-17T22:12:45+00:00 monthly 0.2 https://www.entis-org.eu/meetings/registration-for-the-30th-entis-conference-in-oslo-is-now-open 2018-12-19T12:51:50+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/new-human-teratogens-education-course-launches-in-tampa-fl-usa 2019-07-22T08:30:34+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/uktis-welcomes-new-head-of-service 2019-05-23T10:40:25+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-concerning-the-safety-of-maternal-venlafaxine-use-in-pregnancy 2019-03-06T17:11:45+00:00 monthly 0.2 https://www.entis-org.eu/news/new-meta-analysis-on-fluoroquinolone-exposure-during-pregnancy 2019-02-26T08:02:29+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-of-maternal-and-infant-infection-risk-following-use-of-biologic-medication-in-pregnancy 2019-04-04T11:43:45+00:00 monthly 0.2 https://www.entis-org.eu/news/meta-analysis-of-malformation-risk-following-maternal-ondansetron-use-in-pregnancy 2019-04-04T11:45:19+00:00 monthly 0.2 https://www.entis-org.eu/meetings/30th-annual-conference-2019-oslo-norway-abstract-deadline-approaching 2019-04-11T14:49:24+00:00 monthly 0.2 https://www.entis-org.eu/news/developmental-toxicity-risks-of-medicines-included-on-the-whos-essential-medicines-list 2019-04-04T11:44:03+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-concerning-risks-of-adverse-pregnancy-and-fetal-outcomes-following-maternal-dolutegravir-use 2019-04-11T20:42:47+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/berlin-tis-bids-a-fond-farewell-to-service-founder-and-welcomes-their-new-head-of-service 2019-05-23T10:40:01+00:00 monthly 0.2 https://www.entis-org.eu/news/new-comparative-analysis-of-anti-epileptic-drug-malformation-risks 2019-04-16T20:05:48+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-provides-gestational-teriflunomide-exposure-data 2019-04-16T20:19:02+00:00 monthly 0.2 https://www.entis-org.eu/news/neurodevelopmental-outcomes-in-efavirenz-exposed-infants 2019-04-26T09:28:39+00:00 monthly 0.2 https://www.entis-org.eu/news/additional-data-made-available-concerning-first-trimester-dolutegravir-use 2019-06-05T10:07:10+00:00 monthly 0.2 https://www.entis-org.eu/news/updated-meta-analysis-of-neural-tube-defect-risk-following-clomiphene-use 2019-04-30T18:20:36+00:00 monthly 0.2 https://www.entis-org.eu/news/use-of-real-world-evidence-from-healthcare-utilization-data-to-evaluate-drug-safety-during-pregnancy 2019-05-17T13:02:49+00:00 monthly 0.2 https://www.entis-org.eu/news/interesting-academic-highlights-article-discussing-the-fdas-pregnancy-and-lactation-labelling-rule 2019-05-23T10:38:44+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-on-perceptions-of-medicine-use-among-pregnant-women 2019-06-10T10:04:26+00:00 monthly 0.2 https://www.entis-org.eu/news/vulnerable-populations-at-risk-of-misinformation-about-the-safety-of-medicines-in-pregnancy 2019-06-26T11:28:05+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/imi-conception-project-launch 2019-06-26T14:38:31+00:00 monthly 0.2 https://www.entis-org.eu/news/population-based-study-of-malformation-risks-posed-by-maternal-antibiotic-use 2019-07-01T15:51:09+00:00 monthly 0.2 https://www.entis-org.eu/news/literature-review-risk-of-adverse-fetal-effects-following-short-term-second-trimester-nsaid-use 2019-07-10T08:53:31+00:00 monthly 0.2 https://www.entis-org.eu/news/a-sumamry-of-the-pregnancy-and-lactation-related-enquiries-made-to-the-belgium-national-poison-centre 2019-07-15T09:40:16+00:00 monthly 0.2 https://www.entis-org.eu/news/observational-cohort-study-of-first-trimester-fosfomycin-exposure 2019-07-15T09:50:46+00:00 monthly 0.2 https://www.entis-org.eu/news/study-of-male-genital-anomalies-following-maternal-oral-contraceptive-use-in-pregnancy 2019-07-22T08:18:57+00:00 monthly 0.2 https://www.entis-org.eu/news/consensus-statement-on-the-management-of-individuals-with-fetal-valproate-spectrum-disorder 2019-08-01T09:19:27+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-made-available-concerning-maternal-oseltamivir-use-in-pregnancy 2019-08-12T10:57:48+00:00 monthly 0.2 https://www.entis-org.eu/news/latest-eurap-study-shows-declining-malformation-rate-with-altered-aed-prescribing-practises 2019-08-12T11:07:55+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-investigating-antithyroid-drugs-and-the-risk-of-birth-defects 2019-08-19T12:02:33+00:00 monthly 0.2 https://www.entis-org.eu/news/most-common-birth-defects-among-the-infants-of-women-with-diabetes-in-pregnancy 2019-09-02T15:23:16+00:00 monthly 0.2 https://www.entis-org.eu/meetings/30th-entis-conference-in-oslo-is-nearly-here 2019-10-14T11:11:45+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-official-response-to-the-ema-recommendations-concerning-ondansetron-use-by-pregnant-women 2019-09-19T11:51:20+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/news-from-the-30th-entis-conference-in-oslo 2022-09-12T16:02:57+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/latest-entis-honorary-members 2019-09-23T16:05:01+00:00 monthly 0.2 https://www.entis-org.eu/meetings/annual-meeting-announcement 2019-09-26T15:38:14+00:00 monthly 0.2 https://www.entis-org.eu/news/an-interesting-discussion-of-possible-methodological-approaches-for-dealing-with-data-confounding 2019-09-30T09:01:22+00:00 monthly 0.2 https://www.entis-org.eu/news/using-twitter-for-birth-defect-epidmiology-purposes 2019-10-09T07:12:40+00:00 monthly 0.2 https://www.entis-org.eu/news/national-birth-defects-prevention-study-estimates-of-birth-defect-rates-2010-2014 2019-10-09T07:12:32+00:00 monthly 0.2 https://www.entis-org.eu/news/use-of-spontaneous-reporting-pharmacovigilance-systems-in-detecting-birth-defect-risks 2019-10-14T11:11:19+00:00 monthly 0.2 https://www.entis-org.eu/news/birth-outcomes-following-tdap-vaccination-in-pregnancy 2019-10-23T20:23:04+00:00 monthly 0.2 https://www.entis-org.eu/news/prospective-cohort-study-of-maternal-adalimumab-use-in-pregnancy 2019-10-23T20:28:42+00:00 monthly 0.2 https://www.entis-org.eu/news/collaborative-entis-study-fetotoxic-effects-of-arbs-exceeds-that-of-ace-is 2019-10-30T14:00:39+00:00 monthly 0.2 https://www.entis-org.eu/news/continued-folic-acid-supplementation-beyond-the-early-stages-of-pregnancy-may-have-beneficial-effects-on-child-cognitive-development 2019-11-04T10:03:53+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/congrtualtions-dr-michael-ceulemans 2019-11-07T13:42:40+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/join-us-for-our-inaugural-twitter-journal-club-session-wednesday-nov-20th-at-9pm-gmt 2019-11-12T19:55:38+00:00 monthly 0.2 https://www.entis-org.eu/news/paracetamol-use-in-the-third-trimester-does-not-seem-to-be-associated-with-a-relevant-risk-of-prenatal-ductus-arteriosus-closure-or-fetal-renal-impairment 2019-11-12T20:07:46+00:00 monthly 0.2 https://www.entis-org.eu/news/no-detectable-increased-risk-of-birth-defects-following-maternal-iv-administration-of-ondansetron 2019-11-19T21:56:49+00:00 monthly 0.2 https://www.entis-org.eu/meetings/31st-annual-conference-announcement-preliminary-conference-program-now-available-and-abstract-submission-now-open 2020-08-11T08:15:11+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-published-regarding-the-risk-of-fetal-loss-following-antimalarial-use-in-pregnancy 2019-11-25T20:45:32+00:00 monthly 0.2 https://www.entis-org.eu/news/national-birth-defects-prevention-study-atypical-antipsychotic-use-during-pregnancy-and-birth-defect-risk 2019-12-03T21:05:34+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-attempts-to-quantify-risks-of-stillbirth-among-infants-with-specific-birth-defects 2019-12-11T20:55:17+00:00 monthly 0.2 https://www.entis-org.eu/news/studying-patient-decision-making-aids-for-antidepressant-use-in-pregnancy 2019-12-16T21:36:57+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-finds-increased-risk-of-ventricular-septal-defect-following-first-trimester-ondansetron-use 2019-12-27T15:21:51+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-adverse-pregnancy-outcome-risk-following-abnormal-1-hour-glucose-challenge-test-results 2020-01-06T20:43:57+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/congratulations-to-our-latest-honorary-entis-members 2020-01-08T21:16:27+00:00 monthly 0.2 https://www.entis-org.eu/news/danish-study-describes-a-clinically-important-increased-risk-of-major-congenital-malformation-associated-with-first-trimester-modafinil-exposure 2020-01-31T12:31:50+00:00 monthly 0.2 https://www.entis-org.eu/news/summary-of-current-knowledge-base-concerning-covid-19-infection-in-pregnancy 2020-03-19T07:38:09+00:00 monthly 0.2 https://www.entis-org.eu/news/uk-covid-19-and-pregnancy-guidelines-published 2020-03-23T08:08:13+00:00 monthly 0.2 https://www.entis-org.eu/news/useful-summary-of-the-safety-data-relating-to-hydroxychloroquine-use-in-pregnancy-and-lactation 2020-04-03T07:51:31+00:00 monthly 0.2 https://www.entis-org.eu/news/reports-of-dolutegravir-exposure-and-neural-tube-defects-to-the-who-vigibase 2020-04-28T16:03:43+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-of-reported-cases-of-covid-19-in-pregnancy 2020-04-28T16:08:23+00:00 monthly 0.2 https://www.entis-org.eu/news/updated-acog-committee-opinion-tobacco-and-nicotine-cessation-in-pregnancy 2020-05-04T11:30:21+00:00 monthly 0.2 https://www.entis-org.eu/news/update-on-the-safety-of-azithromycin-use-in-pregnancy-and-breastfeeding 2020-05-11T11:45:44+00:00 monthly 0.2 https://www.entis-org.eu/news/scorpion-envenomation-in-pregnancy 2020-05-18T11:41:30+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-outcomes-in-patients-treated-with-leflunomide 2020-05-18T11:55:46+00:00 monthly 0.2 https://www.entis-org.eu/news/detection-of-sars-cov-2-in-human-breastmilk 2020-05-26T19:33:40+00:00 monthly 0.2 https://www.entis-org.eu/news/oral-fluconazole-associated-with-a-small-increase-in-the-risk-of-musculoskeletal-malformation 2020-05-26T19:47:24+00:00 monthly 0.2 https://www.entis-org.eu/news/study-investigating-neurodevelopment-outcomes-following-caffeine-consumption-in-pregnancy 2020-06-01T11:21:20+00:00 monthly 0.2 https://www.entis-org.eu/news/narrative-review-published-summarising-the-impact-of-coronaviruses-on-pregnant-women 2020-06-01T11:29:23+00:00 monthly 0.2 https://www.entis-org.eu/news/study-of-adverse-fetal-outcomes-following-fexofenadine-use-in-pregnancy 2020-06-10T08:16:37+00:00 monthly 0.2 https://www.entis-org.eu/news/characteristics-and-outcomes-of-pregnant-women-admitted-to-hospital-with-confirmed-sars-cov-2-infection 2020-06-15T15:54:41+00:00 monthly 0.2 https://www.entis-org.eu/news/collaborative-entis-study-of-fingolimod-use-in-pregnancy 2020-06-26T10:38:30+00:00 monthly 0.2 https://www.entis-org.eu/news/large-population-based-cohort-study-finds-no-evidence-that-seasonal-influenza-vaccine-is-associated-with-major-malformation 2020-06-29T14:54:51+00:00 monthly 0.2 https://www.entis-org.eu/entis-study/entis-study-into-how-the-covid-19-pandemic-has-impacted-womens-pregnancy-and-breastfeeding-experiences 2020-07-13T12:56:27+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/changes-to-the-entis-board 2020-07-06T11:34:44+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/online-registration-for-entis-2020-bergamo-is-now-open 2020-07-06T11:43:02+00:00 monthly 0.2 https://www.entis-org.eu/news/associations-between-maternal-antihistamine-use-in-pregnancy-and-fetal-malformation 2020-07-20T12:33:48+00:00 monthly 0.2 https://www.entis-org.eu/news/study-comparing-buprenorphine-and-methadone-in-the-management-of-maternal-opioid-use-disorder 2020-07-27T11:12:34+00:00 monthly 0.2 https://www.entis-org.eu/meetings/save-the-date-virtual-entis-meeting-covid-19-during-pregnancy-and-breastfeeding-current-evidence-research-opportunities-and-tis-experiences 2020-09-16T22:08:51+00:00 monthly 0.2 https://www.entis-org.eu/news/letter-to-the-editor-safety-of-proton-pump-inhibitors-during-pregnancy 2020-08-19T10:16:08+00:00 monthly 0.2 https://www.entis-org.eu/news/review-of-the-fetal-safety-of-medications-used-in-treating-infertility 2020-09-02T16:33:11+00:00 monthly 0.2 https://www.entis-org.eu/meetings/save-the-date-4th-november-virtual-entis-business-meeting 2020-10-27T13:47:11+00:00 monthly 0.2 https://www.entis-org.eu/news/demonstration-of-immortal-time-bias-in-pregnancy-pharmacovigilance-studies 2020-09-14T14:43:33+00:00 monthly 0.2 https://www.entis-org.eu/meetings/covid-19-pregnancy-and-breastfeeding-webinar-meeting-programme 2020-09-16T22:07:09+00:00 monthly 0.2 https://www.entis-org.eu/news/meta-analysis-of-pregnancy-outcomes-following-thiopurine-exposure 2020-09-21T14:21:43+00:00 monthly 0.2 https://www.entis-org.eu/news/small-increased-risk-of-birth-defects-following-first-trimester-hydroxychloroquine-use 2020-09-28T19:43:38+00:00 monthly 0.2 https://www.entis-org.eu/news/long-term-survival-of-children-born-with-congenital-anomalies 2020-10-05T13:03:08+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/should-ondansetron-be-avoided-in-pregnancy 2020-10-07T08:40:47+00:00 monthly 0.2 https://www.entis-org.eu/news/motherisk-journal-article-how-much-folic-acid-is-sufficient-in-women-using-antiepileptic-drugs-during-pregnancy 2020-10-21T15:06:40+00:00 monthly 0.2 https://www.entis-org.eu/news/exploring-the-impact-of-methodological-bias-and-data-confounding-in-pregnancy-pharmacovigilance 2020-10-27T08:56:49+00:00 monthly 0.2 https://www.entis-org.eu/uncategorised/risk-of-neurodevelopment-impairment-following-exposure-to-antiepileptic-drugs-in-pregnancy 2020-10-30T17:49:49+00:00 monthly 0.2 https://www.entis-org.eu/meetings/past-meetings/entis-seminar-on-covid-19-during-pregnancy-and-breastfeeding 2020-10-30T11:34:15+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-outcomes-after-exposure-to-interferon-beta 2020-11-05T20:47:40+00:00 monthly 0.2 https://www.entis-org.eu/news/literature-review-of-the-safety-of-vedolizumab-use-in-pregnant-women-with-inflammatory-bowel-disease 2020-11-09T14:01:00+00:00 monthly 0.2 https://www.entis-org.eu/news/safety-of-direct-oral-anticoagulant-exposure-during-pregnancy 2020-11-30T17:33:13+00:00 monthly 0.2 https://www.entis-org.eu/news/a-demonstration-of-the-considerable-variation-in-stillbirth-definition 2020-12-07T22:09:50+00:00 monthly 0.2 https://www.entis-org.eu/news/no-evidence-for-an-increased-risk-of-adverse-pregnancy-or-birth-outcomes-following-maternal-pertussis-vaccination-in-pregnancy 2020-12-14T17:30:30+00:00 monthly 0.2 https://www.entis-org.eu/news/promoting-collaborations-to-improve-birth-defects-surveillance-research-and-prevention 2020-12-21T14:50:11+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnant-and-breastfeeding-womens-mental-health-status-during-the-first-wave-of-the-covid-19-pandemic 2021-01-29T13:51:18+00:00 monthly 0.2 https://www.entis-org.eu/meetings/save-the-date-virtual-scientific-meeting-tuesday-20th-april-and-27th-may 2021-02-26T08:37:00+00:00 monthly 0.2 https://www.entis-org.eu/news/descriptive-case-series-of-maternal-ivabradine-use-from-the-german-embryotox-database 2021-02-04T21:44:45+00:00 monthly 0.2 https://www.entis-org.eu/news/observational-cohort-study-of-domperidone-use-in-pregnancy 2021-02-26T08:52:14+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/new-members-of-the-entis-scientific-committee 2021-03-08T14:53:08+00:00 monthly 0.2 https://www.entis-org.eu/news/safety-data-for-papaverine-published 2021-03-15T14:34:41+00:00 monthly 0.2 https://www.entis-org.eu/news/review-of-antiepileptic-drug-use-in-pregnancy 2021-03-15T14:33:01+00:00 monthly 0.2 https://www.entis-org.eu/news/vaccine-willingness-and-impact-of-the-covid-19-pandemic-on-womens-perinatal-experiences 2021-03-25T14:23:30+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/scientific-programme-for-the-2021-virtual-meeting 2021-03-31T08:25:44+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-quantifies-the-risk-of-birth-defects-following-exposure-to-antithyroid-drugs 2021-04-07T11:13:39+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-position-statement-covid-19-vaccines-in-pregnancy-and-lactation 2021-04-14T20:06:08+00:00 monthly 0.2 https://www.entis-org.eu/news/preliminary-mrna-cv-19-vaccine-pregnancy-safety-data-released-from-the-us-v-safe-monitoring-system 2021-04-23T12:21:50+00:00 monthly 0.2 https://www.entis-org.eu/news/neonatal-outcomes-following-maternal-sars-cov-2-infection-in-pregnancy 2021-04-26T20:14:29+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-challenge-to-the-ema-prac-recommendations-on-ondansetron-use-in-pregnancy 2021-09-30T20:29:20+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-investigates-the-risk-of-severe-cardiac-malformation-following-antidepressant-use 2021-05-28T15:51:20+00:00 monthly 0.2 https://www.entis-org.eu/meetings/joint-otis-entis-meeting-2024-save-the-date 2021-07-12T10:58:10+00:00 monthly 0.2 https://www.entis-org.eu/news/use-of-a-mobile-app-to-capture-supplemental-health-information-during-pregnancy 2021-07-19T08:47:44+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-on-the-use-of-zonisamide-in-pregnancy 2021-07-19T08:54:07+00:00 monthly 0.2 https://www.entis-org.eu/news/womens-perceptions-of-the-risks-associated-with-dental-imaging-during-pregnancy 2021-07-29T16:14:50+00:00 monthly 0.2 https://www.entis-org.eu/news/case-report-of-tofacitinib-use-during-the-first-trimester 2021-08-02T13:56:00+00:00 monthly 0.2 https://www.entis-org.eu/news/two-cases-of-iv-tocilizumab-treatment-of-covid-19-in-pregnancy 2021-08-16T19:42:23+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/save-the-date-10th-november-2021-virtual-entis-business-meeting 2021-08-17T19:58:00+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-outcome-among-women-with-multiple-sclerosis-a-population-based-study-from-france 2021-08-23T15:50:34+00:00 monthly 0.2 https://www.entis-org.eu/news/covid-19-vaccine-in-pregnancy-preliminary-miscarriage-data-published 2021-08-23T15:56:10+00:00 monthly 0.2 https://www.entis-org.eu/news/tocilizumab-use-for-the-treatment-of-covid-19-in-pregnancy 2021-09-02T12:25:35+00:00 monthly 0.2 https://www.entis-org.eu/news/details-published-of-the-prospective-and-multi-centre-china-teratology-birth-cohort 2021-09-06T15:17:17+00:00 monthly 0.2 https://www.entis-org.eu/news/covid-19-vaccine-in-pregnancy-safety-data 2021-09-06T15:20:59+00:00 monthly 0.2 https://www.entis-org.eu/news/updated-overview-of-the-impact-of-covid-19-in-pregnancy 2021-09-20T16:40:33+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/official-entis-position-statement-paracetamol-acetaminophen-apap-use-in-pregnancy 2021-10-04T18:08:16+00:00 monthly 0.2 https://www.entis-org.eu/meetings/past-meetings/virtual-scientific-meeting-2021 2021-10-13T20:29:35+00:00 monthly 0.2 https://www.entis-org.eu/news/sars-cov-2-infection-and-stillbirth-aetiology 2021-11-03T11:52:09+00:00 monthly 0.2 https://www.entis-org.eu/news/new-data-published-on-the-safety-of-hydroxychloroquine-in-pregnancy 2021-11-08T21:10:18+00:00 monthly 0.2 https://www.entis-org.eu/news/data-published-on-the-safety-metopimazine-use-in-pregnancy 2021-11-17T21:25:22+00:00 monthly 0.2 https://www.entis-org.eu/news/first-trimester-anticoagulant-exposure-in-women-with-preconception-venous-thromboembolism 2021-11-23T20:47:47+00:00 monthly 0.2 https://www.entis-org.eu/news/large-population-based-study-of-duloxetine-use-in-pregnancy-published 2021-12-01T21:26:33+00:00 monthly 0.2 https://www.entis-org.eu/news/interim-results-from-the-biogen-multiple-sclerosis-pregnancy-exposure-registry 2021-12-01T21:32:12+00:00 monthly 0.2 https://www.entis-org.eu/news/is-there-an-optimal-method-for-assessing-fetal-growth-parameters 2021-12-15T10:12:24+00:00 monthly 0.2 https://www.entis-org.eu/meetings/register-now-conception-workshop-moving-pregnancy-pharmacovigilance-into-the-21st-century 2021-12-15T10:20:54+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-scientific-committee-response-to-nature-reviews-endocrinology-consensus-statement-on-paracetamol-acetaminophen-apap-use-in-pregnancy-published 2021-12-15T10:38:58+00:00 monthly 0.2 https://www.entis-org.eu/news/no-evidence-for-an-increased-risk-of-malformation-or-miscarriage-following-ciprofloxacin-use-in-early-pregnancy 2022-01-05T21:55:32+00:00 monthly 0.2 https://www.entis-org.eu/news/safety-of-il-1-blockade-in-pregnancy 2022-01-18T20:43:21+00:00 monthly 0.2 https://www.entis-org.eu/news/medication-use-among-pregnant-and-breastfeeding-women-during-the-covid-19-pandemic 2022-02-21T17:07:16+00:00 monthly 0.2 https://www.entis-org.eu/meetings/annual-conference-2022-call-for-abstract-submission 2022-02-21T17:07:44+00:00 monthly 0.2 https://www.entis-org.eu/news/medication-in-pregnancy-utilisation-study-using-swiss-healthcare-claims-data 2022-03-07T21:22:12+00:00 monthly 0.2 https://www.entis-org.eu/news/paracetamol-acetaminophen-use-in-pregnancy-malformation-and-neurodevelopment-impairment-risks-can-the-data-be-trusted 2022-02-23T09:13:22+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-artemisinin-based-treatment-of-malaria-in-pregnancy 2022-03-07T21:20:54+00:00 monthly 0.2 https://www.entis-org.eu/news/early-pregnancy-tramadol-exposure-not-associated-with-increased-risks-of-miscarriage-or-major-malformation 2022-03-16T21:22:00+00:00 monthly 0.2 https://www.entis-org.eu/news/two-studies-investigating-ms-treatments-in-pregnancy 2022-03-22T21:16:29+00:00 monthly 0.2 https://www.entis-org.eu/news/no-increased-risk-of-malformation-miscarriage-stillbirth-or-neonatal-death-following-mirtazapine-use-in-pregnancy 2022-03-28T20:15:19+00:00 monthly 0.2 https://www.entis-org.eu/news/paternal-exposure-to-antidiabetic-medications-associated-with-increased-birth-defect-risks 2022-04-03T20:32:53+00:00 monthly 0.2 https://www.entis-org.eu/meetings/33rd-annual-conference-2022-registration-now-open 2022-04-03T20:50:53+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/experiences-and-perspectives-of-marketing-authorisation-holders-towards-the-monitoring-of-medication-safety-in-pregnancy 2022-04-06T19:30:31+00:00 monthly 0.2 https://www.entis-org.eu/news/large-study-provides-further-reassurance-about-topical-corticosteroid-use-in-pregnancy 2022-04-25T20:19:23+00:00 monthly 0.2 https://www.entis-org.eu/news/antihypertensive-medication-use-in-pregnancy-linked-with-increased-risks-of-low-birth-weight-and-preterm-birth 2022-05-04T11:39:14+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-protease-inhibitor-based-antiretroviral-therapy-in-pregnancy 2022-05-12T08:24:45+00:00 monthly 0.2 https://www.entis-org.eu/news/monkeypox-and-pregnancy 2022-06-06T12:12:26+00:00 monthly 0.2 https://www.entis-org.eu/news/prenatal-antiseizure-medication-exposure-and-neurodevelopmental-outcomes 2022-06-06T12:20:15+00:00 monthly 0.2 https://www.entis-org.eu/news/meta-analysis-of-adverse-pregnancy-outcome-risk-following-maternal-statin-use-in-pregnancy 2022-06-06T12:33:31+00:00 monthly 0.2 https://www.entis-org.eu/news/swiss-covi-preg-registry-covid-19-mrna-vaccine-in-pregnancy-data-published 2022-06-06T12:37:18+00:00 monthly 0.2 https://www.entis-org.eu/news/topiramate-use-in-pregnancy-associated-with-increased-risks-of-autism-spectrum-disorder-and-intellectual-disability-in-the-offspring 2022-06-13T14:11:37+00:00 monthly 0.2 https://www.entis-org.eu/news/no-link-between-triptan-use-in-pregnancy-and-adhd-in-the-offspring 2022-06-13T14:11:30+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-board-and-scientific-committee-highlight-their-concerns-with-recent-updates-to-the-lyrica-smpc-and-pil-to-the-ema-prac 2022-06-17T14:00:48+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/case-report-of-bosentan-and-sildenafil-use-in-lactation-and-medication-disposition-in-breastmilk 2022-06-27T19:34:27+00:00 monthly 0.2 https://www.entis-org.eu/news/queries-on-medication-use-in-pregnancy-to-the-swiss-teratogen-information-service 2022-06-27T20:09:19+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/position-statement-live-vaccine-use-following-in-utero-or-lactation-infliximab-exposure 2022-07-07T15:35:33+00:00 monthly 0.2 https://www.entis-org.eu/news/language-intelligence-and-educational-outcomes-following-in-utero-anti-seizure-medication-exposure 2022-07-11T16:46:46+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-outcomes-after-first-trimester-exposure-to-buspirone 2022-07-20T20:49:41+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/acetaminophen-paracetamol-in-pregnancy-urogenital-malformations-and-childhood-neurodevelopment 2022-07-25T08:50:28+00:00 monthly 0.2 https://www.entis-org.eu/news/opinion-article-breastfeeding-pregnancy-medicines-neurodevelopment-and-population-databases 2022-08-08T14:50:09+00:00 monthly 0.2 https://www.entis-org.eu/news/no-association-between-maternal-cannabis-use-in-pregnancy-and-adhd-diagnosis-in-the-offspring-in-the-quebec-pregnancy-cohort 2022-08-15T21:33:12+00:00 monthly 0.2 https://www.entis-org.eu/news/the-results-of-post-marketing-pregnancy-or-breastfeeding-safety-studies-have-a-limited-impact-on-medication-product-label-advice 2022-08-22T09:17:16+00:00 monthly 0.2 https://www.entis-org.eu/news/more-evidence-of-the-benefits-of-covid-19-vaccine-in-pregnancy 2022-08-22T09:54:40+00:00 monthly 0.2 https://www.entis-org.eu/news/fetal-toxicity-risks-following-second-or-third-trimester-exposure-to-nsaids-or-metamizole 2022-08-31T18:51:56+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-and-neonatal-outcome-following-alprazolam-exposure-data-from-the-korean-mother-safe-program 2022-09-01T16:19:27+00:00 monthly 0.2 https://www.entis-org.eu/news/fetal-outcomes-following-paternal-or-maternal-5-aminosalicylic-acid-mesalazine-use 2022-09-05T10:42:59+00:00 monthly 0.2 https://www.entis-org.eu/news/society-for-fetal-maternal-medicine-recommendations-for-managing-systemic-lupus-erythematosus-in-pregnancy 2022-09-12T15:35:20+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/the-33rd-annual-entis-conference 2022-10-31T13:07:32+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-outcomes-after-early-fetal-exposure-to-dimethyl-fumarate-glatiramer-acetate-or-natalizumab 2022-09-23T08:57:16+00:00 monthly 0.2 https://www.entis-org.eu/news/case-reports-of-erenumab-exposure-in-pregnancy 2022-09-26T08:31:05+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/presentations-from-the-33rd-annual-conference-now-available-in-the-members-area 2022-11-16T10:26:42+00:00 monthly 0.2 https://www.entis-org.eu/news/multicentre-observational-study-of-natalizumab-for-the-treatment-of-multiple-sclerosis-in-pregnancy 2022-10-03T13:49:20+00:00 monthly 0.2 https://www.entis-org.eu/meetings/34th-annual-entis-conference-to-be-held-in-dublin-ireland 2022-10-03T14:34:59+00:00 monthly 0.2 https://www.entis-org.eu/news/antidepressant-use-in-pregnancy-and-the-risk-of-neurodevelopment-disorders-in-children 2022-10-05T19:28:56+00:00 monthly 0.2 https://www.entis-org.eu/news/descriptive-analysis-of-teratology-counselling-data-from-the-australian-mothersafe-teratology-information-service 2022-10-17T15:06:02+00:00 monthly 0.2 https://www.entis-org.eu/news/an-inventory-of-european-data-sources-for-studying-infant-neurodevelopment-outcomes-following-in-utero-medication-exposure 2022-10-17T15:20:34+00:00 monthly 0.2 https://www.entis-org.eu/news/final-results-from-the-ribavirin-pregnancy-registry-published 2022-10-31T12:57:48+00:00 monthly 0.2 https://www.entis-org.eu/news/use-of-calcium-based-antacids-and-ppis-during-pregnancy-not-found-to-reduce-the-risk-of-late-onset-preeclampsia 2022-11-07T16:33:50+00:00 monthly 0.2 https://www.entis-org.eu/news/nsaid-use-in-the-first-trimester-and-an-increased-risk-of-infants-being-small-for-gestational-age-at-delivery 2022-11-17T16:05:17+00:00 monthly 0.2 https://www.entis-org.eu/news/information-needs-of-parents-of-children-with-congenital-anomalies 2022-11-21T11:21:53+00:00 monthly 0.2 https://www.entis-org.eu/news/a-critical-appraisal-of-the-malformation-risks-following-pregabalin-use-in-early-pregnancy 2022-11-28T15:12:31+00:00 monthly 0.2 https://www.entis-org.eu/news/comparative-entis-study-published-investigating-reproductive-outcomes-following-trazadone-use-in-pregnancy 2022-11-30T12:52:30+00:00 monthly 0.2 https://www.entis-org.eu/news/a-study-of-fetal-and-maternal-outcomes-comparing-buprenorphine-and-methadone-exposure-in-pregnancy 2022-12-07T15:47:44+00:00 monthly 0.2 https://www.entis-org.eu/news/reassuring-evidence-from-a-large-population-based-study-of-antipsychotic-use-and-malformation-risks 2022-12-12T20:41:14+00:00 monthly 0.2 https://www.entis-org.eu/news/no-increased-risk-of-adhd-following-benzodiazepine-z-drug-hypnotic-use-in-pregnancy 2022-12-22T09:23:46+00:00 monthly 0.2 https://www.entis-org.eu/news/maternal-and-perinatal-outcomes-following-pre-delta-delta-and-omicron-sars-cov-2-variants-infection-among-unvaccinated-pregnant-women 2023-01-18T15:18:13+00:00 monthly 0.2 https://www.entis-org.eu/news/large-population-based-study-suggests-no-increased-major-malformation-risk-following-maternal-first-trimester-atomoxetine-use 2023-01-23T15:03:02+00:00 monthly 0.2 https://www.entis-org.eu/news/report-published-on-the-prevalence-and-trends-of-fetal-malformation-in-the-alberta-congenital-anomalies-surveillance-system-1997-to-2019 2023-01-23T15:11:08+00:00 monthly 0.2 https://www.entis-org.eu/news/study-provides-data-on-childhood-infection-risk-following-in-utero-anti-tnf%ce%b1-monoclonal-antibody-exposure 2023-01-30T13:51:56+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-malformation-risk-following-maternal-metformin-use-in-pregnancy 2023-02-06T11:01:08+00:00 monthly 0.2 https://www.entis-org.eu/meetings/34th-annual-entis-conference-dublin-september-2023-call-for-abstracts 2023-02-06T11:15:53+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/pregnancy-and-birth-related-experiences-of-postpartum-women-during-the-third-wave-of-the-covid-19-pandemic 2023-02-13T09:48:48+00:00 monthly 0.2 https://www.entis-org.eu/news/paternal-tyrosine-kinase-inhibitor-exposure-and-pregnancy-outcomes 2023-02-13T09:49:06+00:00 monthly 0.2 https://www.entis-org.eu/news/limited-evidence-of-a-link-between-acetaminophen-paracetamol-and-autism-or-adhd 2023-02-23T13:19:33+00:00 monthly 0.2 https://www.entis-org.eu/news/neurodevelopmental-outcomes-following-antiretroviral-medication-exposure-in-utero 2023-02-27T17:19:50+00:00 monthly 0.2 https://www.entis-org.eu/news/conception-project-communication-toolkit-launch-15th-march 2023-03-03T16:01:49+00:00 monthly 0.2 https://www.entis-org.eu/news/neurodevelopmental-outcome-of-children-exposed-to-pravastatin-in-utero 2023-03-06T13:18:54+00:00 monthly 0.2 https://www.entis-org.eu/news/no-association-between-leukotriene-receptor-antagonist-use-in-pregnancy-and-adhd-asd-or-tourette-syndrome-in-the-offspring 2023-03-13T15:51:25+00:00 monthly 0.2 https://www.entis-org.eu/news/case-report-of-elexacaftor-tezacaftor-ivacaftor-combination-in-pregnancy 2023-03-20T12:42:47+00:00 monthly 0.2 https://www.entis-org.eu/news/study-of-adverse-pregnancy-outcome-risks-following-treatment-of-cmv-with-ganciclovir-or-valganciclovir 2023-04-05T15:21:55+00:00 monthly 0.2 https://www.entis-org.eu/news/imi-conception-recommendations-published-on-the-data-fields-needed-for-pregnancy-pharmacovigilance 2023-03-30T16:11:28+00:00 monthly 0.2 https://www.entis-org.eu/news/observational-study-of-newer-anti-seizure-medication-use-in-pregnancy-focus-on-lacosamide 2023-03-31T10:15:15+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-of-maternal-multiple-sclerosis-birth-outcomes-and-childhood-health-and-neurodevelopement 2023-04-03T11:34:13+00:00 monthly 0.2 https://www.entis-org.eu/news/conception-webinar-invite-using-real-word-data-for-research-on-medication-safety-during-pregnancy-and-breastfeeding 2023-04-05T16:10:36+00:00 monthly 0.2 https://www.entis-org.eu/news/antipsychotic-use-in-pregnancy-and-congenital-malformation-risk 2023-04-12T09:27:28+00:00 monthly 0.2 https://www.entis-org.eu/news/corticosteroid-use-in-pregnancy-for-maternal-ibd-associated-with-an-increased-risk-of-preterm-delivery 2023-04-17T13:41:19+00:00 monthly 0.2 https://www.entis-org.eu/news/in-utero-antiseizure-medication-exposure-and-the-risk-of-psychiatric-disorders 2023-04-24T13:55:57+00:00 monthly 0.2 https://www.entis-org.eu/news/comment-on-the-latest-meta-analysis-investigating-childhood-neurodevelopment-outcomes-following-acetaminophen-paracetamol-use-in-pregnancy 2023-05-04T15:01:19+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/dublin-2023-conference-information-pack-released 2023-05-19T14:56:49+00:00 monthly 0.2 https://www.entis-org.eu/news/cardiac-malformation-risk-following-first-trimester-methylphenidate-use-in-pregnancy 2023-05-22T09:33:32+00:00 monthly 0.2 https://www.entis-org.eu/news/new-case-control-study-investigating-covid-19-mrna-booster-vaccination-and-miscarriage 2023-05-22T10:13:18+00:00 monthly 0.2 https://www.entis-org.eu/news/overview-of-the-development-and-design-of-the-belpreg-registration-system 2023-05-24T10:37:58+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-comparing-propylthiouracil-and-methimazole-safety-in-pregnancy 2023-05-31T08:19:10+00:00 monthly 0.2 https://www.entis-org.eu/news/updated-systematic-review-and-meta-analysis-of-malformation-risk-after-proton-pump-inhibitor-exposure 2023-06-05T10:46:17+00:00 monthly 0.2 https://www.entis-org.eu/news/expert-consensus-published-focusing-on-the-study-of-neurodevelopmental-outcomes-in-pregnancy-drug-safety-studies 2023-06-14T07:28:25+00:00 monthly 0.2 https://www.entis-org.eu/news/congenital-malformation-risks-following-integrase-inhibitor-use-in-pregnancy 2023-06-21T11:25:05+00:00 monthly 0.2 https://www.entis-org.eu/news/malformation-risks-following-first-trimester-covid-19-vaccination 2023-06-28T08:16:47+00:00 monthly 0.2 https://www.entis-org.eu/meetings/34th-entis-annual-conference-programme-released 2023-08-14T15:45:28+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-and-fetal-outcomes-following-maternal-use-of-glatiramer-acetate 2023-08-14T15:10:08+00:00 monthly 0.2 https://www.entis-org.eu/news/case-series-of-pregnancy-and-fetal-outcomes-following-maternal-use-of-long-acting-injectable-antipsychotics-during-pregnancy 2023-08-14T15:28:05+00:00 monthly 0.2 https://www.entis-org.eu/news/consensus-recommendations-on-the-management-of-depressive-disorders-in-pregnancy 2023-08-14T15:38:07+00:00 monthly 0.2 https://www.entis-org.eu/news/european-society-for-medical-oncology-publish-expert-consensus-recommendations-on-the-management-of-breast-cancer-during-pregnancy 2023-08-21T08:38:46+00:00 monthly 0.2 https://www.entis-org.eu/meetings/entis-otis-2024-save-the-date 2023-08-31T09:35:52+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/34th-annual-entis-meeting-ends 2023-09-21T13:06:17+00:00 monthly 0.2 https://www.entis-org.eu/news/results-from-the-avonex-pregnancy-registry-published 2023-09-25T07:48:50+00:00 monthly 0.2 https://www.entis-org.eu/news/vedolizumab-and-ustekinumab-exposed-pregnancies-reported-from-the-piano-registry 2023-10-09T08:25:20+00:00 monthly 0.2 https://www.entis-org.eu/news/levetiracetam-use-in-pregnancy-data-from-the-embryotox-cohort 2023-10-24T08:43:24+00:00 monthly 0.2 https://www.entis-org.eu/news/dose-related-association-between-third-trimester-levetiracetam-and-lamotrigine-use-and-impairments-of-adaptive-functioning-in-the-offspring 2023-11-22T13:12:41+00:00 monthly 0.2 https://www.entis-org.eu/news/comparison-of-defects-self-reported-by-mothers-with-data-provided-by-general-practitioners 2023-11-27T12:23:02+00:00 monthly 0.2 https://www.entis-org.eu/news/in-utero-cannabis-exposure-associated-with-increased-risks-of-fetal-growth-impairment-preterm-birth-and-nicu-admission 2023-12-04T13:14:21+00:00 monthly 0.2 https://www.entis-org.eu/news/effects-of-maternal-modafinil-treatment-on-fetal-development-and-neonatal-growth-parameters 2023-12-20T12:00:11+00:00 monthly 0.2 https://www.entis-org.eu/news/improving-data-collection-in-pregnancy-safety-studies-a-study-from-the-imi-conception-project 2023-12-20T12:29:08+00:00 monthly 0.2 https://www.entis-org.eu/news/impact-of-maternal-first-trimester-valproate-treatment-regimen-on-the-risk-of-birth-defects 2024-01-10T13:34:58+00:00 monthly 0.2 https://www.entis-org.eu/news/study-of-379-pregnancies-exposed-to-dimethyl-fumarate 2024-01-10T13:49:08+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-of-pregnancy-safety-data-for-small-molecules-used-in-the-treatment-of-inflammatory-bowel-disease 2024-01-15T15:11:11+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-experts-respond-to-study-assessing-brain-morphologic-trajectory-following-prenatal-ssri-exposure 2024-01-17T12:10:22+00:00 monthly 0.2 https://www.entis-org.eu/news/joint-entis-otis-meeting-2024-nyborg-denmark-call-for-abstracts 2024-03-26T22:03:48+00:00 monthly 0.2 https://www.entis-org.eu/news/belpreg-a-real-world-data-source-on-medication-use-in-pregnancy-in-belgium 2024-01-31T11:04:26+00:00 monthly 0.2 https://www.entis-org.eu/news/an-updated-systematic-review-and-meta-analysis-of-neonatal-outcomes-among-pregnant-women-with-asthma 2024-02-12T08:47:49+00:00 monthly 0.2 https://www.entis-org.eu/news/live-births-following-leflunomide-exposure-and-malformation-risks 2024-03-13T12:17:08+00:00 monthly 0.2 https://www.entis-org.eu/news/medication-use-in-pregnancy-on-the-rise 2024-03-18T15:14:50+00:00 monthly 0.2 https://www.entis-org.eu/news/study-finds-no-increased-risk-of-autism-spectrum-disorder-with-maternal-topiramate-use-in-pregnancy 2024-03-25T10:43:53+00:00 monthly 0.2 https://www.entis-org.eu/news/entis-otis-2024-conference-website-launched 2024-03-26T22:01:59+00:00 monthly 0.2 https://www.entis-org.eu/news/safety-data-for-fibrate-use-in-pregnancy-published 2024-04-03T10:55:42+00:00 monthly 0.2 https://www.entis-org.eu/news/entis-otis-2024-registration-now-open 2024-04-04T08:08:10+00:00 monthly 0.2 https://www.entis-org.eu/news/paternal-glatiramer-acetate-use-not-associated-with-increased-risks-of-adverse-pregnancy-or-fetal-outcomes 2024-04-08T11:07:28+00:00 monthly 0.2 https://www.entis-org.eu/meetings/entis-otis-2024-late-abstract-submission-deadline-announced 2024-04-08T11:11:46+00:00 monthly 0.2 https://www.entis-org.eu/news/sibling-controlled-cohort-study-finds-no-evidence-for-an-increased-risk-of-autism-adhd-or-intellectual-disability-following-paracetamol-acetaminophen-use-in-pregnancy 2024-04-10T07:35:30+00:00 monthly 0.2 https://www.entis-org.eu/news/collaborative-entis-study-published-investigating-the-safety-of-glp1-receptor-agonists-in-early-pregnancy 2024-10-02T07:41:24+00:00 monthly 0.2 https://www.entis-org.eu/news/anti-seizure-medication-in-pregnancy-practice-guidelines-published 2024-05-20T11:24:41+00:00 monthly 0.2 https://www.entis-org.eu/news/large-population-based-cohort-study-finds-no-increased-risk-of-miscarriage-following-macrolide-antibiotic-use 2024-06-05T07:39:46+00:00 monthly 0.2 https://www.entis-org.eu/news/study-finds-no-increased-risk-of-malformation-neurodevelopmental-disorder-or-autism-spectrum-disorder-in-the-children-of-male-valproate-users 2024-06-10T11:42:03+00:00 monthly 0.2 https://www.entis-org.eu/news/reappraisal-of-the-safety-data-for-biological-dmards-in-treating-inflammatory-arthritis-suggests-that-the-benefits-of-use-outweigh-the-risks 2024-06-19T09:35:53+00:00 monthly 0.2 https://www.entis-org.eu/news/therapeutic-amfetamine-use-during-breastfeeding-and-child-neurodevelopment 2024-06-28T15:10:32+00:00 monthly 0.2 https://www.entis-org.eu/news/prenatal-exposure-to-benzodiazepine-and-z-hypnotics-and-fifth-grade-scholastic-skills 2024-07-01T07:58:25+00:00 monthly 0.2 https://www.entis-org.eu/news/no-increased-risk-of-major-malformation-following-first-trimester-fluoroquinolone-use 2024-07-01T08:17:46+00:00 monthly 0.2 https://www.entis-org.eu/news/manufacturer-of-golimumab-publishes-pregnancy-safety-data 2024-07-08T10:23:09+00:00 monthly 0.2 https://www.entis-org.eu/news/international-collaborative-study-and-systematic-review-of-allopurinol-safety-in-pregnancy 2024-07-11T15:11:09+00:00 monthly 0.2 https://www.entis-org.eu/news/data-published-from-the-covacpreg-french-prospective-cohort-study-of-covid-19-vaccination-during-pregnancy 2024-07-15T09:19:05+00:00 monthly 0.2 https://www.entis-org.eu/news/suspected-vertical-transmission-of-oropouche-virus-in-pregnancy 2024-07-22T15:41:48+00:00 monthly 0.2 https://www.entis-org.eu/news/entis-and-otis-comment-on-the-precautionary-regulatory-measures-for-paternal-valproate-use 2024-08-28T09:38:15+00:00 monthly 0.2 https://www.entis-org.eu/news/entis-partners-develop-new-algorithm-to-detect-and-date-early-non-live-pregnancy-outcomes-in-liked-norwegian-health-registries 2024-09-27T10:50:18+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/nyborg-welcomes-delegates-to-the-2024-entis-otis-conference 2024-09-19T08:02:16+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/close-of-entis-otis-nyborg-2024 2025-04-17T11:03:02+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/presentations-from-entis-otis-2024-now-available-in-the-members-area 2024-09-25T16:07:27+00:00 monthly 0.2 https://www.entis-org.eu/news/oropouche-virus-orov-in-pregnancy-a-helpful-narrative-review 2024-09-30T12:56:56+00:00 monthly 0.2 https://www.entis-org.eu/news/entis-collaborative-study-published-modafinil 2024-10-02T07:39:25+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-studies-investigating-neonatal-outcomes-following-maternal-use-of-antipsychotics 2024-10-03T13:39:49+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-malformation-risks-associated-with-dolutegravir 2024-10-09T10:12:23+00:00 monthly 0.2 https://www.entis-org.eu/news/oropouche-virus-case-series-of-newborns-with-microcephaly-in-brazil 2024-10-17T07:59:33+00:00 monthly 0.2 https://www.entis-org.eu/news/entis-scientific-committee-commentary-published-paternal-valproate 2024-10-18T10:56:26+00:00 monthly 0.2 https://www.entis-org.eu/news/paternal-metformin-use-and-risk-of-congenital-malformation 2024-10-21T15:05:23+00:00 monthly 0.2 https://www.entis-org.eu/news/berlin-tis-demonstrates-the-use-of-landmarking-for-the-analysis-of-left-truncated-competing-risk-data 2024-11-04T13:22:54+00:00 monthly 0.2 https://www.entis-org.eu/news/large-population-based-study-of-first-trimester-tetracycline-use-and-major-congenital-malformation-risks 2024-11-20T16:14:13+00:00 monthly 0.2 https://www.entis-org.eu/news/latest-data-released-from-the-german-ms-pregnancy-registry 2024-12-12T12:32:52+00:00 monthly 0.2 https://www.entis-org.eu/news/acetaminophen-adhd-and-asd-a-clinical-perspective-jointly-published-by-the-entis-otis-scientific-committees 2024-12-12T13:04:04+00:00 monthly 0.2 https://www.entis-org.eu/news/data-published-by-tis-berlin-trends-in-first-trimester-antiseizure-medication-use-and-treatment-patterns 2024-12-23T13:56:18+00:00 monthly 0.2 https://www.entis-org.eu/news/neurodevelopmental-outcomes-following-prenatal-exposure-to-systemic-glucocorticoids 2025-01-13T09:48:56+00:00 monthly 0.2 https://www.entis-org.eu/news/additional-data-on-certolizumab-pegol-published-from-japanese-pharmacovigilance-database 2025-01-20T17:16:16+00:00 monthly 0.2 https://www.entis-org.eu/news/influenza-vaccination-in-pregnancy 2025-01-27T16:26:02+00:00 monthly 0.2 https://www.entis-org.eu/news/euromedicat-study-investigating-ocular-anomalies-and-prenatal-medication-use 2025-02-05T11:42:49+00:00 monthly 0.2 https://www.entis-org.eu/news/guidance-published-on-the-statistical-analysis-and-reporting-of-single-arm-pregnancy-medication-safety-studies 2025-02-06T09:43:49+00:00 monthly 0.2 https://www.entis-org.eu/news/latest-studies-and-publications 2025-02-10T11:57:17+00:00 monthly 0.2 https://www.entis-org.eu/news/new-publications-from-entis-partners 2025-02-19T13:49:59+00:00 monthly 0.2 https://www.entis-org.eu/news/study-finds-no-increased-risk-of-malformation-following-first-trimester-pseudoephedrine-exposure 2025-02-24T13:46:12+00:00 monthly 0.2 https://www.entis-org.eu/news/latest-publications-from-entis-members 2025-03-31T08:28:44+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-of-the-risks-of-cabergoline-use-in-pregnancy-published 2025-03-31T08:55:21+00:00 monthly 0.2 https://www.entis-org.eu/news/eular-2024-update-published 2025-04-28T07:45:47+00:00 monthly 0.2 https://www.entis-org.eu/news/risk-of-autism-spectrum-disorder-following-maternal-antiseizure-medication-use-in-pregnancy 2025-05-16T09:38:36+00:00 monthly 0.2 https://www.entis-org.eu/news/nationwide-cohort-study-investigating-fetal-and-childhood-outcomes-following-maternal-statin-use-in-pregnancy 2025-05-19T11:30:18+00:00 monthly 0.2 https://www.entis-org.eu/news/latest-publications-from-tis-paris-cochin 2025-07-11T13:46:08+00:00 monthly 0.2 https://www.entis-org.eu/news/case-series-of-feviparivir-exposure-in-pregnancy-published-by-terafar-izmir-tis 2025-07-21T16:14:14+00:00 monthly 0.2 https://www.entis-org.eu/news/prospective-case-series-of-pregnancy-outcomes-following-gestational-cftr-modulator-use-published 2025-07-21T16:20:00+00:00 monthly 0.2 https://www.entis-org.eu/news/acog-issues-statement-on-the-benefit-of-access-to-ssris-during-pregnancy 2025-07-23T10:19:27+00:00 monthly 0.2 https://www.entis-org.eu/news/conception-project-milk4baby-decision-trees-published 2025-08-06T07:29:50+00:00 monthly 0.2 https://www.entis-org.eu/news/does-extended-follow-up-period-after-birth-improve-precision-of-diagnosis-of-congenital-anomalies 2025-08-27T15:29:00+00:00 monthly 0.2 https://www.entis-org.eu/news/study-of-prenatal-psychotropic-drug-exposures-on-obstetric-complications-in-a-large-population-based-dataset 2025-09-08T09:13:32+00:00 monthly 0.2 https://www.entis-org.eu/news/latest-publications 2025-09-15T14:32:21+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/goodbye-to-thessaloniki 2025-09-15T15:26:23+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/37th-entis-meeting-location-announcement 2025-09-15T15:46:24+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/presentations-from-the-36th-annual-entis-conference-in-thessaloniki-are-now-available-in-the-members-area 2025-09-22T11:31:01+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/joint-eapcct-entis-webinar-clinical-approach-to-poisoning-in-a-pregnant-woman-register-today 2025-09-25T09:58:41+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-position-statement-paracetamol-in-pregnancy-and-autism-spectrum-disorder 2025-09-29T07:10:10+00:00 monthly 0.2 https://www.entis-org.eu/news/updated-analysis-of-tofacitinib-global-safety-database-published 2025-09-29T09:23:42+00:00 monthly 0.2 https://www.entis-org.eu/news/zika-virus-and-neurodevelopmental-outcomes-a-systematic-review-and-meta-analysis 2025-10-06T09:36:29+00:00 monthly 0.2 https://www.entis-org.eu/news/commentary-published-discussing-a-recent-study-of-acetaminophen-exposure-and-childhood-attention-deficit-hyperactivity-disorder 2025-10-10T09:27:53+00:00 monthly 0.2 https://www.entis-org.eu/news/modafinil-armodafinil-pregnancy-exposure-registry-final-analysis-published 2025-10-15T14:15:16+00:00 monthly 0.2 https://www.entis-org.eu/news/norwegian-case-control-study-shows-association-between-adhd-medication-use-and-miscarriage 2025-11-10T10:36:11+00:00 monthly 0.2 https://www.entis-org.eu/news/umbrella-review-of-systematic-reviews-investigating-claims-of-increased-asd-and-adhd-risks-following-maternal-paracetamol-use-published 2025-11-10T10:43:39+00:00 monthly 0.2 https://www.entis-org.eu/news/commentary-published-on-the-fda-panel-discussion-about-ssri-use-in-pregnancy 2025-11-12T09:52:00+00:00 monthly 0.2 https://www.entis-org.eu/news/new-study-published-investigating-neurodevelopmental-delay-risks-following-paternal-valproate-use 2025-11-21T08:59:40+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-and-meta-analysis-of-pregnancy-outcomes-following-paternal-methotrexate-exposure-published 2025-11-17T14:44:06+00:00 monthly 0.2 https://www.entis-org.eu/news/critical-evaluation-published-on-the-latest-review-of-neurodevelopmental-disorders-following-in-utero-exposure-to-acetaminophen-paracetamol 2025-11-20T20:17:35+00:00 monthly 0.2 https://www.entis-org.eu/uncategorised/disproportionality-analysis-of-pregnancy-cftr-modulator-reports-in-vigibase 2025-11-24T10:00:03+00:00 monthly 0.2 https://www.entis-org.eu/news/pregnancy-outcomes-following-unintentional-exposure-to-a-live-attenuated-tetravalent-dengue-vaccine 2025-11-24T10:28:45+00:00 monthly 0.2 https://www.entis-org.eu/news/paternal-dmard-exposure-and-neonatal-outcomes 2025-12-01T13:47:27+00:00 monthly 0.2 https://www.entis-org.eu/news/disproportionality-analysis-of-pregnancy-janus-kinase-inhibitor-reports-in-vigibase 2025-12-01T13:56:30+00:00 monthly 0.2 https://www.entis-org.eu/news/neurodevelopmental-outcomes-following-antiemetic-use-in-pregnancy 2025-12-08T16:43:00+00:00 monthly 0.2 https://www.entis-org.eu/news/nationwide-cohort-study-of-unintentional-periconceptual-glucagon-like-peptide-1-receptor-agonist-use-and-pregnancy-outcomes 2025-12-08T17:05:24+00:00 monthly 0.2 https://www.entis-org.eu/news/population-based-study-of-systemic-lupus-erythematosus-in-pregnancy 2025-12-15T11:11:03+00:00 monthly 0.2 https://www.entis-org.eu/news/nationwide-cross-sectional-utilisation-study-of-recommended-drugs-for-pregnancy-in-france 2026-01-12T10:19:27+00:00 monthly 0.2 https://www.entis-org.eu/meetings/annual-entis-meeting-leiden-nl-call-for-abstracts 2026-01-21T14:59:00+00:00 monthly 0.2 https://www.entis-org.eu/news/comparing-the-capture-of-covid-19-vaccination-in-pregnancy-in-commercial-insurance-claims-records-and-electronic-health-records 2026-01-26T13:39:12+00:00 monthly 0.2 https://www.entis-org.eu/news/miscarriage-and-stillbirth-risks-following-ondansetron-use-in-pregnancy 2026-02-02T16:53:19+00:00 monthly 0.2 https://www.entis-org.eu/news/miscarriage-risks-and-migraine-medication-use 2026-02-02T16:57:25+00:00 monthly 0.2 https://www.entis-org.eu/news/exploratory-analysis-of-major-congenital-malformation-risk-following-first-trimester-antidepressant-use-either-alone-or-with-co-medication 2026-02-09T10:08:59+00:00 monthly 0.2 https://www.entis-org.eu/news/study-examines-maternal-and-fetal-outcomes-following-statin-discontinuation-in-pregnancy 2026-02-23T14:19:47+00:00 monthly 0.2 https://www.entis-org.eu/uncategorised/case-reports-published-detailing-galcanezumab-use-in-pregnancy 2026-03-02T12:22:58+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/entis-welcomes-a-new-member-organisation-the-norwegian-relis-network 2026-03-06T14:06:05+00:00 monthly 0.2 https://www.entis-org.eu/news/living-systematic-review-of-mpox-vaccine-use-in-pregnancy 2026-03-09T13:15:18+00:00 monthly 0.2 https://www.entis-org.eu/news/new-sibling-controlled-study-on-acetaminophen-paracetamol-use-in-pregnancy-and-adhd-asd 2026-03-16T10:58:32+00:00 monthly 0.2 https://www.entis-org.eu/news/japanese-tis-publishes-comparative-cohort-study-assessing-statin-use-in-early-pregnancy 2026-03-16T11:05:03+00:00 monthly 0.2 https://www.entis-org.eu/news/french-nationwide-cohort-study-finds-association-between-nsaid-use-in-pregnancy-and-miscarriage-risk 2026-03-23T16:58:26+00:00 monthly 0.2 https://www.entis-org.eu/news/target-trial-emulation-studying-the-timing-of-high-dose-folic-acid-supplementation-among-women-taking-antiseizure-medications-and-malformation-risk 2026-03-30T10:02:54+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/tis-zerifin-publish-comparative-cohort-study-of-ondansetron-use-in-pregnancy 2026-03-30T10:09:31+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/meta-analysis-of-paternal-metformin-use-and-major-malformation-risk-published 2026-04-08T11:43:09+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/neonatal-outcomes-following-maternal-pertussis-vaccination-in-pregnancy 2026-04-08T11:43:37+00:00 monthly 0.2 https://www.entis-org.eu/news/a-systematic-safety-surveillance-approach-assessing-congenital-malformation-risk-following-prenatal-antipsychotic-exposure 2026-04-13T09:12:16+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/data-from-the-belpreg-cohort-published 2026-04-13T09:29:43+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/observational-cohort-study-examining-the-safety-of-medicines-used-to-treat-nausea-and-vomiting-in-pregnancy 2026-04-17T15:39:23+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/study-comparing-self-reported-maternal-health-and-pregnancy-outcome-data-against-medical-record-data 2026-04-17T15:43:07+00:00 monthly 0.2 https://www.entis-org.eu/news/systematic-review-of-neurodevelopmental-disorders-following-in-utero-topiramate-exposure 2026-04-20T07:34:59+00:00 monthly 0.2 https://www.entis-org.eu/meetings/annual-conference-programme-published 2026-04-22T16:25:46+00:00 monthly 0.2 https://www.entis-org.eu/entis-news/phd-defence-laure-sillis-june-4-2026-ku-leuven 2026-04-24T06:28:24+00:00 monthly 0.2 https://www.entis-org.eu/news/post-approval-safety-study-of-rsv-prefusion-f-subunit-based-vaccine-rsvpref 2026-04-27T08:25:10+00:00 monthly 0.2